RNXT
RNXT clinical trials: RenovoRx, Inc.
Every trial on ClinicalTrials.gov where RenovoRx, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
RNXT on the catalyst calendar · RNXT registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Jun 2027Sponsor estimate | NCT03257033Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCRenovoRx · Locally Advanced Pancreatic Cancer | RNXTLead | Phase 3 | Active, not recruiting | Locked | Locked | Locked |
| Sep 3, 2029Sponsor estimate | NCT06805461PumaRx Registry TrialRenovoRx · Solid Tumors | RNXTLead | No phase registered | Recruiting | Locked | Locked | Locked |
| Feb 26, 2021Actual | NCT02591082Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 CatheterRenovoRx · Pancreatic Neoplasms | RNXTLead | No phase registered | Completed | Locked | Locked | Locked |
| Sep 2016Actual | NCT02237157A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic CancerRenovoRx · Pancreatic Cancer | RNXTLead | Phase 1 | Completed | Locked | Locked | Locked |
- Primary completion Jun 2027Sponsor estimatePhase 3NCT03257033Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCRenovoRx · Locally Advanced Pancreatic CancerActive, not recruitingRNXTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 3, 2029Sponsor estimateNo phase registeredNCT06805461PumaRx Registry TrialRenovoRx · Solid TumorsRecruitingRNXTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 26, 2021ActualNo phase registeredNCT02591082Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 CatheterRenovoRx · Pancreatic NeoplasmsCompletedRNXTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2016ActualPhase 1NCT02237157A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic CancerRenovoRx · Pancreatic CancerCompletedRNXTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner